• 1
    Soloway MS. The management of superficial bladder cancer. Cancer 1980; 45: 185665
  • 2
    Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer. progression and recurrence. J Urol 1983; 130: 10836
  • 3
    Ali-El-Dein B, El-Baz M, Nabeeh A, Shamaa S, Ashamallah A. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study. J Urol 1997; 158: 6874
  • 4
    Heney NM. Natural history of superficial bladder cancer: Prognostic features and long-term disease course. Urol Clin North Am 1992; 19: 42933
  • 5
    Fitzpatrick JM, West AB, Butler MR et al. Superficial bladder tumors (stages pTa, grades 1 and 2). The importance of recurrence pattern following initial resection. J Urol 1986; 135: 9202
  • 6
    Ali-El-Dein B, Nabeeh A, Ismail E et al. Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: a randomized prospective study. J Urol 1999; 162: 33942
  • 7
    Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 738
  • 8
    Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 47581
  • 9
    Peto R, Peto J. Asymptotically efficient rank in variant procedures. J R Stat Soc Series A 1972; 135: 185207
  • 10
    Cox DR. Regression models and life tables. J R Stat Soc Series B 1972; 34: 187
  • 11
    Feldman AR, Kessler L, Myer M et al. The prevalence of cancer. Estimates based on Connecticut Tumor Registry. New Engl J Med 1986; 315: 13946
  • 12
    Herr HW, Laudone VP, Whitmore WF et al. An overview of intravesical therapy for superficial bladder tumors. J Urol 1987; 138: 13638
  • 13
    Kurth KH, Sylvester R, De Pauw M et al. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience. In DebruyneFMJ, DenisL, Van Der MeydenAMP eds, EORTC Genitourinary Group Monograph 6: BCG in Superficial Bladder Cancer. New York: Alan R. Liss, 1989: 12545
  • 14
    Dalesio O, Schulman CC, Sylvester R et al. Prognostic factors in superficial bladder tumors. A study of the European Organisation for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol 1983; 129: 7303
  • 15
    Herr HW, Badalament RA, Amato DA et al. Superficial bladder cancer treated with bacillus Calmette-Guerin. A multivariate analysis of factors affecting tumor progression. J Urol 1989; 141: 229
  • 16
    Parmar MKB, Freedman LS, Hargreave TB et al. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on superficial bladder cancer (Urological Cancer Working Party). J Urol 1989; 142: 2848
  • 17
    Mulders PFA, Van Der Meyden APM, Doesburg WH et al. Prognostic factors in pTa-pT1 superficial bladder tumors treated with intravesical instillations. Br J Urol 1994; 73: 4038
  • 18
    Sato N, Sumiya H, Isaka S et al. Prognostic factors for progression of superficial bladder cancer. Jap J Urol 1992; 83: 12639
  • 19
    Chopin DK, Popov Z, Ravery V et al. Prognostic factors in superficial bladder cancer. World J Urol 1993; 11: 14852
  • 20
    Fitzpatrick JM. Superficial bladder carcinoma. Factors affecting the natural history. World J Urol 1993; 11: 1427
  • 21
    Reading J, Hall RR, Parmar MKB. The application of a prognostic factor analysis for Ta. T1 bladder cancer in routine urological practice. Br J Urol 1995; 75: 6047
  • 22
    Allard P, Bernard P, Fradet Y et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998; 81: 6928
  • 23
    Hemstreet GP III, Rollins S, Jones P et al. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. J Urol 1991; 146: 15259
  • 24
    Van Velthoven R, Petein M, Oosterlinck WJ et al. The use of digital image analysis of chromatin texture in Feulgen-stained nuclei to predict recurrence of low grade superficial transitional cell carcinoma of the bladder. Cancer 1995; 75: 5608
  • 25
    Stein JP, Grossfeld GD, Ginsberg DA et al. Prognostic markers in bladder cancer. a contemporary review of the literature. J Urol 1998; 160: 64559
  • 26
    Ghoneim MA, El-Mekresh MM, Mokhtar AA et al. A predictive model of survival after radical cystectomy for carcinoma of the bladder. BJU Int 2000; 85: 8116
  • 27
    Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997; 12: 48894
  • 28
    Witjes JA, Kiemeney LALM, Verbeek AL et al. Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients. World J Urol 1992; 10: 2314
  • 29
    Kiemeney LALM, Witjes JA, Heijbroek RP et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993; 150: 604
  • 30
    Skinka T, Matsumoto M, Ogura H et al. Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guerin: a long-term followup. Int J Urol 1997; 4: 139
  • 31
    Gustafson H, Tribukait B. Characterization of bladder carcinoma by flow DNA analysis. Eur Urol 1985; 11: 4107
  • 32
    Blomjous ECM, Schipper NW, Baak JPA et al. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Path 1989; 91: 2438
  • 33
    Solsona E, Iborra I, Dumont R et al. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer. J Urol 2000; 164: 6859
  • 34
    Hinev AI, Diacov C. Computer assisted metaphylaxis of superficial bladder tumors. J BUON 1996; 1: 11